BRIDGEBIO PHARMA INC (BBIO)

US10806X1028 - Common Stock

28.12  -0.08 (-0.28%)

After market: 28.14 +0.02 (+0.07%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
217.76M9.30M77.65M69.72M8.25M
Minority Interest Expense
7.43M10.05M3.47M23.92M56.76M
Cost Of Goods
2.39M2.45M3.43M3.11M0.00
Gross Profit
215.37M6.86M74.21M66.60M8.25M
Operating Expenses
748.07M606.30M542.65M643.24M482.73M
Research and Development
506.34M455.71M399.46M451.02M337.05M
Selling, General, and Administrative Expenses
241.73M150.59M143.19M192.21M145.68M
Operating Income
-532.70M-599.44M-468.43M-576.63M-474.48M
Interest Income/Expense
-56.68M-44.94M35.05M-45.65M-32.64M
Other Income/Expense
3.02M-944.00K-7.50M35.82M1.63M
Non Recurring Items
140.06M-7.93M-43.77MN/AN/A
Income Before Taxes
-446.29M-653.25M-484.65M-586.45M-505.49M
Net Income
-438.86M-643.20M-481.18M-562.54M-448.72M
EBITDA
-526.40M-592.95M-461.66M-570.79MN/A
 
Per Share Data
EPS Diluted Total Ops
-2.41-3.95-3.26-3.90-3.80
Non GAAP EPS
-2.65-3.94-3.11-3.91-3.80
 
Statistics
Gross Profit Margin
98.90%73.71%95.57%95.52%100.00%
Profit Margin
-201.53%-6913.92%-619.68%-806.86%-5439.03%
Operating Profit Margin
-244.62%-6443.56%-603.26%-827.07%-5751.27%

All data in USD

Charts